1. Home
  2. BSX vs SIGIP Comparison

BSX vs SIGIP Comparison

Compare BSX & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • SIGIP
  • Stock Information
  • Founded
  • BSX 1979
  • SIGIP N/A
  • Country
  • BSX United States
  • SIGIP United States
  • Employees
  • BSX N/A
  • SIGIP 2800
  • Industry
  • BSX Medical/Dental Instruments
  • SIGIP Property-Casualty Insurers
  • Sector
  • BSX Health Care
  • SIGIP Finance
  • Exchange
  • BSX Nasdaq
  • SIGIP Nasdaq
  • Market Cap
  • BSX 138.5B
  • SIGIP N/A
  • IPO Year
  • BSX 1992
  • SIGIP N/A
  • Fundamental
  • Price
  • BSX $93.25
  • SIGIP $17.20
  • Analyst Decision
  • BSX Strong Buy
  • SIGIP
  • Analyst Count
  • BSX 23
  • SIGIP 0
  • Target Price
  • BSX $107.61
  • SIGIP N/A
  • AVG Volume (30 Days)
  • BSX 10.1M
  • SIGIP N/A
  • Earning Date
  • BSX 04-23-2025
  • SIGIP N/A
  • Dividend Yield
  • BSX N/A
  • SIGIP N/A
  • EPS Growth
  • BSX 16.82
  • SIGIP N/A
  • EPS
  • BSX 1.25
  • SIGIP N/A
  • Revenue
  • BSX $16,747,000,000.00
  • SIGIP N/A
  • Revenue This Year
  • BSX $15.60
  • SIGIP N/A
  • Revenue Next Year
  • BSX $10.28
  • SIGIP N/A
  • P/E Ratio
  • BSX $76.10
  • SIGIP N/A
  • Revenue Growth
  • BSX 17.61
  • SIGIP N/A
  • 52 Week Low
  • BSX $66.80
  • SIGIP N/A
  • 52 Week High
  • BSX $107.17
  • SIGIP N/A
  • Technical
  • Relative Strength Index (RSI)
  • BSX 45.80
  • SIGIP 42.56
  • Support Level
  • BSX $86.77
  • SIGIP $16.90
  • Resistance Level
  • BSX $96.69
  • SIGIP $17.47
  • Average True Range (ATR)
  • BSX 4.05
  • SIGIP 0.31
  • MACD
  • BSX -0.02
  • SIGIP -0.05
  • Stochastic Oscillator
  • BSX 59.74
  • SIGIP 39.45

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.

Share on Social Networks: